Literature DB >> 22218743

The actual role of sodium cromoglycate in the treatment of asthma--a critical review.

Nikolaus C Netzer1, T Küpper, Hans W Voss, Arn H Eliasson.   

Abstract

INTRODUCTION: Despite international consensus and clearly written guidelines urging wider use of corticosteroids or combinations of inhaled short- and long-acting β-agonists (SABA and LABA) and corticosteroids in persistent asthma, prescribing patterns and compliance rates fall far short of recommendations.
OBJECTIVES: The failure to use steroids more aggressively is due, in part, to their side effects, even with inhaled forms of the drug. There is a role for expanded use of sodium cromolyn in asthma. Its potent anti-inflammatory effects, lack of side effects, and acceptable dosing and method of delivery, as well as its special role in exercise-induced asthma, make it a very suitable choice in the initial therapy for control of asthma.
CONCLUSION: Compared to SABA and LABA, cromoglycates alone are unsuspicious of being used to enhance physical performance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218743     DOI: 10.1007/s11325-011-0639-1

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  58 in total

Review 1.  Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment.

Authors:  C Randolph
Journal:  Curr Probl Pediatr       Date:  1997-02

2.  Effect of fenoterol hydrobromide and sodium cromoglycate individually and in combination on postexercise asthma.

Authors:  P S Clarke; D A Ratowsky
Journal:  Ann Allergy       Date:  1990-02

3.  Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium.

Authors:  E F Juniper; K M Latimer; M M Morris; R S Roberts; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  1986-09       Impact factor: 10.793

4.  Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination.

Authors:  I Mitchell; I C Paterson; S J Cameron; I W Grant
Journal:  Br Med J       Date:  1976-08-21

Review 5.  Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications.

Authors:  O D Wolthers; J W Honour
Journal:  J Asthma       Date:  1999-09       Impact factor: 2.515

6.  A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma.

Authors:  M Hoshino; Y Nakamura; J J Sim; H Tomioka
Journal:  Respir Med       Date:  1998-07       Impact factor: 3.415

Review 7.  Keeping children with exercise-induced asthma active.

Authors:  H Milgrom; L M Taussig
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

8.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

Authors:  L Agertoft; S Pedersen
Journal:  Respir Med       Date:  1994-05       Impact factor: 3.415

Review 9.  Inhaled sodium cromoglycate for asthma in children.

Authors:  Johannes C van der Wouden; Johannes H J M Uijen; Roos M D Bernsen; Marjolein J A Tasche; Johan C de Jongste; Francine Ducharme
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

10.  Dose-response study of sodium cromoglycate in exercise-induced asthma.

Authors:  K R Patel; K E Berkin; J W Kerr
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

View more
  3 in total

Review 1.  Pharmacotherapy of critical asthma syndrome: current and emerging therapies.

Authors:  T E Albertson; M Schivo; N Gidwani; N J Kenyon; M E Sutter; A L Chan; S Louie
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

Review 2.  Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties.

Authors:  Angélique Mottais; Tony Le Gall; Yann Sibiril; Julian Ravel; Véronique Laurent; Frédérique d'Arbonneau; Tristan Montier
Journal:  Biosci Rep       Date:  2017-11-17       Impact factor: 3.840

3.  Cromolyn, a New Hope for Limited Treatment of Neutrophilic Asthma: a Phase II Randomized Clinical Trial.

Authors:  Majid Mirsadraee; Zahra Sabbagh Sajadieh; Shadi Ghafari; Afsaneh Tavakoli; Saeedeh Sabbagh Sajadieh
Journal:  Tanaffos       Date:  2019-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.